• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Iran strikes 85 U.S. military sites in the Gulf, sparking a global selloff in stocks and a spike in the price of oil

2

Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it

3

Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI

1

Iran strikes 85 U.S. military sites in the Gulf, sparking a global selloff in stocks and a spike in the price of oil

2

Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it

3

Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI
C-SuitePharmaceutical Industry

The CEO who loves AI autodidacts — and desperately needs his experts

Nick Lichtenberg
By
Nick Lichtenberg
Nick Lichtenberg
Business Editor
Down Arrow Button Icon
Nick Lichtenberg
By
Nick Lichtenberg
Nick Lichtenberg
Business Editor
Down Arrow Button Icon
June 3, 2026, 9:00 AM ET
bb
Amgen CEO Robert "Bob" Bradway.courtesy of Amgen
Add Fortune on Google for similar content.

Bob Bradway has a word for the kind of leader who will thrive in the AI era: “autodidact.” Curious. Self-taught. Comfortable with uncertainty. The kind of person who picks up a new tool on a Saturday and figures it out by Sunday — which, as it happens, is exactly what Bradway himself does.

Recommended Video

The Amgen CEO spends his weekends vibe-coding, has required his entire senior executive team to take AI courses, and talks about artificial intelligence with a rare fluency. In a podcast interview with AI pioneer Andrew Ng, he was told: “A lot of times you sound more like an AI person than a biotech CEO.”

The irony is that Bradway runs a company built on the opposite of the autodidact. Amgen’s competitive moat is its experts — scientists who have spent decades learning that molecules are delicate constructions indeed. “The hallways are full of people who have the experience of understanding if you make a substitution of one amino acid for another, there’s a consequence,” Bradway said. “We want to be very careful not to lose that.”

Reconciling those two things — the adaptable generalist and the irreplaceable specialist — is the central challenge of Bradway’s AI moment. And few CEOs are better positioned to navigate it. That’s because Bradway didn’t just start thinking about AI recently. He started in 2012.

That year, Amgen acquired DeCODE Genetics, a small Icelandic company holding longitudinal genomic data on virtually the entire population of Iceland — not a drug or a patent, but a bet that data and AI would eventually transform how medicines get discovered. His peers were skeptical. Even Andrew Ng, who would later become a close collaborator, told Bradway at the time that the genetic data wasn’t “tractable” yet and steered him toward nearer-term AI applications like computer vision. Bradway made both bets and today, an Nvidia SuperPod hums in Reykjavik, Amgen has developed its own protein folding models, and the company is actively pursuing zero-shot antibody design — using AI to engineer drug molecules without prior experimental examples.

The results are tangible, Bradway said. Amgen is now selecting drug candidates for clinical development roughly 50% faster than before. Rather than relying solely on DeepMind’s celebrated AlphaFold, Bradway pushed his team to look past the hype and identify precisely what the model could and couldn’t do for their specific needs — then build on top of it. “We’re not relying on any single approach,” he said.

Amgen told Fortune that it has several “tangible examples” of how AI is additive and supportive to its teams’ work, with a focus on freeing up time for them to focus on what really moves the needle in terms of getting medicines to patients. It has reduced production line clearance time at one manufacturing site from approximately 30 minutes to about two minutes per batch run, and in certain trials, participants were enrolled up to three times more efficiently, according to the company. AI tools and training available companywide include Microsoft Copilot and OpenAI’s ChatGPT Enterprise, alongside investments in training education and responsible-use frameworks. 

His next frontier is agentic AI, and the timeline is explicit: “2026 is the year we all need to figure out what agentic AI is.” The opportunity, as he described it, is profound: scientists today burn hours filling out forms, requisitioning materials, summarizing data — work that agentic systems could absorb entirely, freeing researchers to do what only they can do. “That’s magic,” he said. It’s also where the autodidact-versus-expert tension gets resolved, in Bradway’s telling: AI is liberating, rather than displacing. “Hopefully they have more time to use the essence of their skill,” he said, “and less time devoted to menial things.”

Whether that reassurance lands with employees is another matter. Bradway acknowledged that America broadly doesn’t trust AI and that uncertainty breeds anxiety. “There is a lot of misinformation and there’s a lot of uncertainty and humans hate the unknown, right? Humans don’t like to be kept in the dark and so the more we can share transparently what we’re doing, I think the better.” Still, he admitted, “I don’t have the answer to that, although as you can see, I’m an optimist.”

He’s also, at this point, a proven one. While other CEOs are still debating AI’s return on investment, Bradway is openly baffled by the hand-wringing. “I read a lot and hear a lot about people expressing frustration that they’re not earning a return from the investments that they’re making. I’m a little bit puzzled by that,” he said. Then again, he noted that in biotech, patience isn’t optional and a single molecule can consume a decade-and-a-half, so maybe his “bewilderment” is down to the different calculus. The companies that can’t tolerate uncertainty, he implied, may be precisely the ones that fall behind.

Historically, the process with molecules has relied heavily on iterative laboratory work, manual data review and sequential testing, and AI can help researchers analyze significantly larger datasets, model molecular behavior, predict protein structures, and evaluate candidate molecules earlier in the process. The goal, Amgen said, is to deprioritize less promising candidates earlier. 

“Being late to this party is going to be expensive,” he said. “Being early to the party has the potential for real benefit.”

For this story, Fortune journalists used generative AI as a research tool. An editor verified the accuracy of the information before publishing.

Subscribe to Fortune Gulf Brief. Every Tuesday, this new newsletter delivers clear-eyed, authoritative intelligence on the deals, decisions, policies, and power shifts shaping one of the world’s most consequential regions, written for the people who need to act on it. Sign up here.
About the Author
Nick Lichtenberg
By Nick LichtenbergBusiness Editor
LinkedIn icon

Nick Lichtenberg is business editor and was formerly Fortune's executive editor of global news.

See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in C-Suite

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in C-Suite

Cathie Wood just bought the SpaceX dip again—and dumped Alibaba to do it
InvestingCathie Wood
Cathie Wood just bought the SpaceX dip again—and dumped Alibaba to do it
By Marco Quiroz-GutierrezJuly 8, 2026
14 hours ago
How Qualcomm’s CIO is placing big bets on AI to support the chip company’s diversification push
NewslettersCIO Intelligence
How Qualcomm’s CIO is placing big bets on AI to support the chip company’s diversification push
By John KellJuly 8, 2026
14 hours ago
Andrew Forrest, chairman of Fortescue Metals Group Ltd., during a panel session at the World Economic Forum (WEF) Annual Meeting of the New Champions in Dalian, China, on Tuesday, June 23, 2026.
C-SuiteLeadership
Mining CEO worth $24 billion nearly drowned and had to break his own leg in a freak hiking accident—he used the recovery time to go back to school
By Eleanor PringleJuly 8, 2026
16 hours ago
Meet the former Goldman Sachs exec who became the America’s Cup Partnership’s first CEO and is running the 175-year-old trophy like a startup
C-SuiteSports
Meet the former Goldman Sachs exec who became the America’s Cup Partnership’s first CEO and is running the 175-year-old trophy like a startup
By Catherina GioinoJuly 7, 2026
2 days ago
Photo: Asha Sharma
North AmericaMarkets
Game over for 20% of Xbox staff as Microsoft hits reset: We ‘didn’t focus on the core business,’ CEO says. ‘We simply spread ourselves too thin.’
By Jim EdwardsJuly 7, 2026
2 days ago
Indra Nooyi sitting in a chair behind a red background.
SuccessCareers
Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it
By Preston ForeJuly 6, 2026
3 days ago

Most Popular

Iran strikes 85 U.S. military sites in the Gulf, sparking a global selloff in stocks and a spike in the price of oil
Newsletters
Iran strikes 85 U.S. military sites in the Gulf, sparking a global selloff in stocks and a spike in the price of oil
By Jim EdwardsJuly 8, 2026
22 hours ago
Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it
Success
Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it
By Preston ForeJuly 6, 2026
3 days ago
Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI
AI
Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI
By Marco Quiroz-GutierrezJuly 5, 2026
4 days ago
Current price of oil as of July 8, 2026
Personal Finance
Current price of oil as of July 8, 2026
By Joseph HostetlerJuly 8, 2026
19 hours ago
Billionaires John and Laura Arnold have already donated nearly half their wealth. Now they're funding a hunt for the health risks of sports betting
Success
Billionaires John and Laura Arnold have already donated nearly half their wealth. Now they're funding a hunt for the health risks of sports betting
By Sydney LakeJuly 8, 2026
1 day ago
Investment firm's cofounder sues after being fired for neglecting the in-person work mandate he signed, saying it applies to employees not owners
Law
Investment firm's cofounder sues after being fired for neglecting the in-person work mandate he signed, saying it applies to employees not owners
By Jason MaJuly 5, 2026
4 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.